Vanguard (UTI) amendment shows 0 shares beneficially owned after realignment
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Universal Technical Institute Inc Schedule 13G/A amendment shows The Vanguard Group reports 0 shares beneficially owned of Common Stock (CUSIP 913915104), representing 0% of the class. The filing explains an internal realignment effective January 12, 2026 under SEC Release No. 34-39538, with certain Vanguard subsidiaries reporting disaggregated ownership separately. The amendment is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Positive
- None.
Negative
- None.
FAQ
What did Vanguard report on Schedule 13G/A for UTI?
Vanguard reported beneficial ownership of 0 shares, representing 0% of UTI's common stock. The amendment states this follows an internal realignment and separate reporting by Vanguard subsidiaries under SEC Release No. 34-39538.
Why does the filing mention SEC Release No. 34-39538?
Because Vanguard relied on Release No. 34-39538 to disaggregate subsidiary holdings. The filing explains certain subsidiaries now report beneficial ownership separately after a realignment dated January 12, 2026.
Who signed the Schedule 13G/A amendment for Vanguard and when?
The amendment was signed by Ashley Grim, Head of Global Fund Administration. The signature is dated 03/27/2026, certifying the amended disclosures on behalf of Vanguard.